The antioxidant activity of daidzein metabolites, O‑desmethylangolensin and equol, in HepG2 cells

Choi,Eun  Jeong; Kim,Gun‑Hee

doi:10.3892/mmr.2013.1752

The antioxidant activity of daidzein metabolites, O‑desmethylangolensin and equol, in HepG2 cells

Authors:
- Eun Jeong Choi
- Gun‑Hee Kim
View Affiliations

Affiliations: Plant Resources Research Institute, Duksung Women's University, Dobong‑ku, Seoul 132‑701, Republic of Korea
Published online on: October 23, 2013 https://doi.org/10.3892/mmr.2013.1752
Pages: 328-332

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Daidzein and its glycoside form daidzin, are known to have potential health benefits and are metabolized to O‑desmethylangolensin (O‑DMA) and equol following consumption. In the current study, the antioxidant activity and cytotoxicity of O‑DMA, equol, daidzein and daidzin was investigated and their effects on HepG2 human hepatocelluar carcinoma cells were compared. For cytotoxicity assays, lactose dehydrogenase (LDH) release and 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide‑based cell viability, cells were exposed to various concentrations of each compound (5‑200 µM) for 24, 48 or 72 h. O‑DMA and equol did not affect LDH release, but higher concentrations (<75 µM) showed inhibition of cell growth. By contrast, daidzein and daidzin (200 µM) increased LDH release and cell growth. All compounds stimulated catalase and total superoxide dismutase (SOD) (CuZn‑ and Mn‑SOD) activity, and mRNA and protein expression. This phenomenon was most pronounced for O‑DMA and equol, as their effects were similar. These data suggested that O‑DMA and equol possess greater antioxidant properties compared with daidzein and may, thus, be beneficial for human health.

View Figures

View References

1	Bors W, Michel C and Stettmaier K: Antioxidant effects of flavonoids. Biofactors. 6:399–402. 1997. View Article : Google Scholar : PubMed/NCBI
2	Kris-Etherton PM and Keen CL: Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 13:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
3	Hirooka Y, Sagara Y, Kishi T and Sunagawa K: Oxidative stress and central cardiovascular regulation. Pathogenesis of hypertension and therapeutic aspects. Circ J. 74:827–835. 2010. View Article : Google Scholar : PubMed/NCBI
4	Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
5	L’homme R, Brouwers E, Al-Maharik N, Lapcík O, Hampl R, Mikola H, Wähälä K and Adlercreutz H: Time-resolved fluoroimmunoassay of plasma and urine O-desmethylangolensin. J Steroid Biochem Mol Biol. 81:353–361. 2002.PubMed/NCBI
6	Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H and Watanabe S: Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 10:127–135. 2000. View Article : Google Scholar : PubMed/NCBI
7	Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA and Peeters PH: Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol. 25:648–655. 2007. View Article : Google Scholar : PubMed/NCBI
8	Hwang J, Wang J, Morazzoni P, Hodis HN and Sevanian A: The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic Biol Med. 34:1271–1282. 2003. View Article : Google Scholar
9	Turner R, Baron T, Wolffram S, Minihane AM, Cassidy A, Rimbach G and Weinberg PD: Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res. 38:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
10	Rüfer CE and Kulling SE: Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem. 54:2926–2931. 2006.PubMed/NCBI
11	Aebi H: Catalase in vitro. Methods Enzymol. 105:121–126. 1984. View Article : Google Scholar
12	Marklund S and Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469–474. 1974. View Article : Google Scholar : PubMed/NCBI
13	Toda S and Shirataki Y: Comparison of antioxidative and chelating effects of daidzein and daidzin on protein oxidative modification by copper in vitro. Biol Trace Elem Res. 79:83–89. 2001. View Article : Google Scholar : PubMed/NCBI
14	Messina M: A brief historical overview of the past two decades of soy and isoflavone research. J Nutr. 140:1350S–1354S. 2010. View Article : Google Scholar : PubMed/NCBI
15	Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F and Testolin G: Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch Biochem Biophys. 433:421–427. 2005. View Article : Google Scholar : PubMed/NCBI
16	Setchell KD, Brown NM and Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 132:3577–3584. 2002.PubMed/NCBI
17	Bolca S, Possemiers S, Herregat A, Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De Keukeleire D, Bracke M, De Henauw S, Verstraete W and Van de Wiele T: Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr. 137:2242–2246. 2007.
18	Jackman KA, Woodman OL and Sobey CG: Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem. 14:2824–2830. 2007. View Article : Google Scholar : PubMed/NCBI
19	Knasmüller S, Mersch-Sundermann V, Kevekordes S, Darroudi F, Huber WW, Hoelzl C, Bichler J and Majer BJ: Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology. 198:315–328. 2004.PubMed/NCBI
20	Zhang R, Sun J, Ma L, Wu X, Pan G, Hao H, Zhou F, AJ, Liu C, Ai H, Shang L, Gao H, Peng Y, Wan P, Wu H and Wang G: Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. Toxicol Appl Pharmacol. 252:18–27. 2011. View Article : Google Scholar
21	Choi EJ: Chronic equol administration attenuates the antioxidant defense system and causes apoptosis in the mouse brain. Food Chem Toxicol. 47:1779–1784. 2009. View Article : Google Scholar : PubMed/NCBI
22	Choi EJ: Evaluation of equol function on anti- or prooxidant status in vivo. J Food Sci. 74:H65–H71. 2009. View Article : Google Scholar : PubMed/NCBI
23	Choi EJ: The prooxidant, rather than antioxidant, acts of daidzein in vivo and in vitro: daidzein suppresses glutathione metabolism. Eur J Pharmacol. 542:162–169. 2006. View Article : Google Scholar : PubMed/NCBI
24	Okayasu H, Ishihara M, Satoh K and Sakagami H: Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines. Anticancer Res. 21:2387–2392. 2001.PubMed/NCBI
25	Palozza P, Serini S, Di Nicuolo F, Piccioni E and Calviello G: Prooxidant effects of beta-carotene in cultured cells. Mol Aspects Med. 24:353–362. 2003. View Article : Google Scholar : PubMed/NCBI
26	Tafazoli S, Wright JS and O’Brien PJ: Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem Res Toxicol. 18:1567–1574. 2005. View Article : Google Scholar : PubMed/NCBI
27	Watała C, Budziejewska A and JóŸwiak Z: Alloxan-induced alterations in composition and dynamics of red blood cell membranes. I Effect of alloxan on intact red blood cells and isolated erythrocyte membranes. Biochem Pharmacol. 38:1793–1798. 1989.PubMed/NCBI
28	Jendrossek V: The intrinsic apoptosis pathways as a target in anticancer therapy. Curr Pharm Biotechnol. 13:1426–1438. 2012. View Article : Google Scholar : PubMed/NCBI
29	Mansilla S, Llovera L and Portugal J: Chemotherapeutic targeting of cell death pathways. Anticancer Agents Med Chem. 12:226–238. 2012. View Article : Google Scholar
30	Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H and Leonart ME: Oxidative stress and cancer: an overview. Ageing Res Rev. 12:376–390. 2013. View Article : Google Scholar : PubMed/NCBI
31	Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP and Rice-Evans CA: Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 26:63–70. 1997. View Article : Google Scholar : PubMed/NCBI
32	Murota K and Terao J: Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 417:12–17. 2003. View Article : Google Scholar : PubMed/NCBI
33	Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer Invest. 21:744–757. 2003. View Article : Google Scholar : PubMed/NCBI
34	Zaitsev M, Steinhoff S and Shah NJ: Error reduction and parameter optimization of the TAPIR method for fast T1 mapping. Magn Reson Med. 49:1121–1132. 2003. View Article : Google Scholar : PubMed/NCBI
35	Cobb JM, Mattice JD, Senseman SA, Dumas JA, Mersie W, Riley MB, Potter TL, Mueller TC and Watson EB: Stability of pesticides on solid-phase extraction disks after incubation at various temperatures and for various time intervals: interlaboratory study. J AOAC Int. 89:903–912. 2006.
36	Jackman KA, Woodman OL, Chrissobolis S and Sobey CG: Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Res. 1141:99–107. 2007. View Article : Google Scholar : PubMed/NCBI
37	Birt DF, Hendrich S and Wang W: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther. 90:157–177. 2001. View Article : Google Scholar : PubMed/NCBI
38	Cotelle N: Role of flavonoids in oxidative stress. Curr Top Med Chem. 1:569–590. 2001. View Article : Google Scholar : PubMed/NCBI
39	Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI